Cutaquig 165 mg/mL

Cutaquig 165 mg/mL is a subcutaneous immunoglobulin G solution used to treat immune deficiencies. This product, manufactured by Pfizer, helps support the immune system in individuals with specific conditions.

Cutaquig 165 mg/mL is primarily used for immune system support in patients with primary immunodeficiency. This medication is designed to replace missing antibodies, helping the body fight infections. It is often prescribed for conditions where the immune system is not functioning properly, providing essential protection against various pathogens.

Common effects of Cutaquig 165 mg/mL may include redness, swelling, or itching at the injection site. Some users might experience mild to moderate discomfort during or after administration. These effects are generally temporary and should subside over time.

Cutaquig 165 mg/mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow the guidance of a healthcare professional when using this medication. Always check the packaging for any specific instructions related to storage and usage.

Cutaquig 165 mg/mL may interact with certain medications, so it is important to inform your healthcare provider about all the drugs you are taking. Alcohol and other substances that affect the immune system should be discussed with a medical professional to avoid potential interactions.